Antlia Bioscience, Inc. — Form D
Antlia Bioscience, Inc. of ENCINITAS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-05. The offering totals $20.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-06-05
- Form: D
- Accession: 0001829522-26-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $6.0M
- Remaining: $14.0M
- Investors: 3
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-586295
Issuer
- Name: Antlia Bioscience, Inc.
- CIK: 0001829522
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1281 HYMETTUS AVE, ENCINITAS, CA, 92024
- Phone: 619-990-0290
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ben Auspitz | Related Person | Cambridge, MA |
| Carlos Garcia Echeverria | Related Person | Encinitas, CA |
| Brian Laurence Johnson | Related Person | Encinitas, CA |
| Ankit Mahadevia | Related Person | Cambridge, MA |
| Nihal Sinha | Related Person | Encinitas, CA |
| Martin Taylor | Related Person | Encinitas, CA |
| Brian Laurence Johnson | Director | Encinitas, CA |
| Brian Laurence Johnson | Executive Officer | Encinitas, CA |
Other filings by this issuer (2)
More